⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1859490 | 0.77 | — | — | |
| SCHEMBL28745074 | 0.75 | — | — | |
| SCHEMBL3292700 | 0.62 | — | — | |
| SCHEMBL27505441 | 0.62 | — | — | |
| SCHEMBL30882139 | 0.61 | — | — | |
| SCHEMBL26830983 | 0.60 | — | — | |
| SCHEMBL762171 | 0.60 | — | — | |
| SCHEMBL22578140 | 0.60 | — | — | |
| SCHEMBL9208942 | 0.60 | — | — | |
| SCHEMBL13912592 | 0.60 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5049694-A | Cardiovascular disorders | CEDONA PHARMACEUTICALS B.V. (NL) | 1991-09-17 | — | — | US | claimed |
| EP-0359335-A2 | Pharmaceutical composition having relaxing activity which contains a nitrate ester as active substance | CEDONA PHARMACEUTICALS B.V. (NL) | 1990-03-21 | — | — | EP | claimed |
| EP-2347775-B1 | SCAFFOLDS FOR CELL TRANSPLANTATION | HARVARD COLLEGE (US) | 2020-04-15 | — | — | EP | disclosed |
| US-20190125849-A1 | SCAFFOLDS FOR CELL TRANSPLANTATION | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2019-05-02 | — | — | US | disclosed |
| US-10149897-B2 | Scaffolds for cell transplantation | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2018-12-11 | — | — | US | disclosed |
| US-10137184-B2 | Scaffolds for cell transplantation | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2018-11-27 | — | — | US | disclosed |
| EP-2347774-B1 | Scaffolds for cell transplantation | THE PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2017-07-26 | — | — | EP | disclosed |
| US-20160279220-A1 | Scaffolds For Cell Transplantation | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2016-09-29 | — | — | US | disclosed |
| US-20160279219-A1 | Scaffolds For Cell Transplantation | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2016-09-29 | — | — | US | disclosed |
| US-20160271298-A1 | SCAFFOLDS FOR CELL TRANSPLANTATION | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2016-09-22 | — | — | US | disclosed |
| US-9446107-B2 | Scaffolds for cell transplantation | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2016-09-20 | — | — | US | disclosed |
| EP-1960009-B1 | SCAFFOLDS FOR CELL TRANSPLANTATION | HARVARD COLLEGE (US) | 2011-11-23 | — | — | EP | disclosed |
| EP-2347774-A1 | Scaffolds for cell transplantation | The President and Fellows of Harvard College (US) | 2011-07-27 | — | — | EP | disclosed |
| EP-2347775-A1 | Scaffolds for cell transplantation | The President and Fellows of Harvard College (US) | 2011-07-27 | — | — | EP | disclosed |
| EP-1960009-A2 | SCAFFOLDS FOR CELL TRANSPLANTATION | The President and Fellows of Harvard College (US) | 2008-08-27 | — | — | EP | disclosed |
| US-20080044900-A1 | Scaffolds for cell transplantation | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2008-02-21 | — | — | US | disclosed |
| WO-2007070660-A9 | SCAFFOLDS FOR CELL TRANSPLANTATION | HARVARD COLLEGE (US) | 2007-08-02 | — | — | WO | disclosed |
| WO-2007070660-A2 | SCAFFOLDS FOR CELL TRANSPLANTATION | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2007-06-21 | — | — | WO | disclosed |
| US-5049694-A | Cardiovascular disorders | CEDONA PHARMACEUTICALS B.V. (NL) | 1991-09-17 | — | — | US | disclosed |
| EP-0359335-A2 | Pharmaceutical composition having relaxing activity which contains a nitrate ester as active substance | CEDONA PHARMACEUTICALS B.V. (NL) | 1990-03-21 | — | — | EP | disclosed |